Eliza W Beal1, Fabio Bagante1, Anghela Paredes1, Qinyu Chen1, Ozgur Akgul1, Katiuscha Merath1, Mary E Dillhoff1, Jordan M Cloyd1, Timothy M Pawlik2,3. 1. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. 2. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu. 3. Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center, 395 W. 12th Ave., Suite 670, Columbus, OH, USA. tim.pawlik@osumc.edu.
Abstract
INTRODUCTION: The Center for Medicare and Medicaid Services (CMS) has identified readmission as an important quality metric. With an increased emphasis on regionalization of complex hepato-pancreato-biliary (HPB) surgery to high-volume centers, care of readmitted HPB patients may be fragmented if readmission occurs at a non-index hospital. We sought to define the proportion of HPB readmissions, as well as evaluate outcomes, that occur at an index versus non-index hospitals and to identify factors associated with non-index hospital readmission. METHODS: The National Readmissions Database (NRD) was used to identify patients who underwent major HPB surgery between 2010 and 2015. Factors associated with readmission at 30 and 90 days at index versus non-index hospitals were analyzed. Differences in mortality and complications were analyzed among patients readmitted to index versus non-index hospitals. RESULTS: A total of 49,080 patients underwent HPB surgery (liver n = 27,081, 55%; pancreas n = 14,787, 30%; biliary n = 7212, 15%). Overall, 6643 (14%) and 11,709 (24%) patients were readmitted within 30 and 90 days, respectively. Among all first readmissions, 18 and 21% were to a non-index hospital within the first 30 and 90 days, respectively. On multivariable analysis, factors associated with readmission to a non-index hospital included age (OR 1.19, 95% CI 1.05, 1.34), pancreatic cancer (OR 1.40, 95% CI 1.14, 1.34) and ≥ 3 comorbidities (OR 1.34, 95% CI 1.10, 1.63), while procedures on the pancreas (OR 0.69, 95% CI 0.61, 0.80), private insurance (OR 0.77, 95% CI 0.68, 0.87), initial admission at a large hospital (OR 0.77, 95% CI 0.65, 0.91), and initial admission length of stay > 7 days (OR 0.77, 95% CI 0.69, 0.86) were associated with decreased odds of a non-index hospital readmission (all p < 0.05). Patients readmitted to a non-index hospital had higher inpatient mortality (3.7 vs. 2.7%, p = 0.010). CONCLUSIONS: Roughly 1 in 5 patients were readmitted to a non-index hospital where the initial HPB operation had not taken place. Readmission to a non-index hospital was associated with higher overall in-hospital mortality. The impact of regionalization of HPB care relative to site of subsequent readmission may have important implications for patients.
INTRODUCTION: The Center for Medicare and Medicaid Services (CMS) has identified readmission as an important quality metric. With an increased emphasis on regionalization of complex hepato-pancreato-biliary (HPB) surgery to high-volume centers, care of readmitted HPB patients may be fragmented if readmission occurs at a non-index hospital. We sought to define the proportion of HPB readmissions, as well as evaluate outcomes, that occur at an index versus non-index hospitals and to identify factors associated with non-index hospital readmission. METHODS: The National Readmissions Database (NRD) was used to identify patients who underwent major HPB surgery between 2010 and 2015. Factors associated with readmission at 30 and 90 days at index versus non-index hospitals were analyzed. Differences in mortality and complications were analyzed among patients readmitted to index versus non-index hospitals. RESULTS: A total of 49,080 patients underwent HPB surgery (liver n = 27,081, 55%; pancreas n = 14,787, 30%; biliary n = 7212, 15%). Overall, 6643 (14%) and 11,709 (24%) patients were readmitted within 30 and 90 days, respectively. Among all first readmissions, 18 and 21% were to a non-index hospital within the first 30 and 90 days, respectively. On multivariable analysis, factors associated with readmission to a non-index hospital included age (OR 1.19, 95% CI 1.05, 1.34), pancreatic cancer (OR 1.40, 95% CI 1.14, 1.34) and ≥ 3 comorbidities (OR 1.34, 95% CI 1.10, 1.63), while procedures on the pancreas (OR 0.69, 95% CI 0.61, 0.80), private insurance (OR 0.77, 95% CI 0.68, 0.87), initial admission at a large hospital (OR 0.77, 95% CI 0.65, 0.91), and initial admission length of stay > 7 days (OR 0.77, 95% CI 0.69, 0.86) were associated with decreased odds of a non-index hospital readmission (all p < 0.05). Patients readmitted to a non-index hospital had higher inpatient mortality (3.7 vs. 2.7%, p = 0.010). CONCLUSIONS: Roughly 1 in 5 patients were readmitted to a non-index hospital where the initial HPB operation had not taken place. Readmission to a non-index hospital was associated with higher overall in-hospital mortality. The impact of regionalization of HPB care relative to site of subsequent readmission may have important implications for patients.
Entities:
Keywords:
Care fragmentation; Index readmission; Non-index readmission
Authors: Eran Sadot; Murray F Brennan; Ser Yee Lee; Peter J Allen; Mithat Gönen; Jeffery S Groeger; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; Yuman Fong Journal: Ann Surg Oncol Date: 2014-07-22 Impact factor: 5.344
Authors: Finlay A McAlister; Erik Youngson; Jeffrey A Bakal; Padma Kaul; Justin Ezekowitz; Carl van Walraven Journal: CMAJ Date: 2013-08-19 Impact factor: 8.262
Authors: Eric B Schneider; Aslam Ejaz; Gaya Spolverato; Kenzo Hirose; Martin A Makary; Christopher L Wolfgang; Nita Ahuja; Matthew Weiss; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2014-10-09 Impact factor: 3.452
Authors: Carl van Walraven; Monica Taljaard; Edward Etchells; Chaim M Bell; Ian G Stiell; Kelly Zarnke; Alan J Forster Journal: J Hosp Med Date: 2010-09 Impact factor: 2.960
Authors: Gregory A Williams; Jingxia Liu; William C Chapman; William G Hawkins; Ryan C Fields; Dominic E Sanford; Majella B Doyle; Chet W Hammill; Adeel S Khan; Steven M Strasberg Journal: J Gastrointest Surg Date: 2019-12-16 Impact factor: 3.452
Authors: Sameer A Hirji; Edward D Percy; Cheryl K Zogg; Muthiah Vaduganathan; Spencer Kiehm; Marc Pelletier; Tsuyoshi Kaneko Journal: Ann Thorac Surg Date: 2020-01-21 Impact factor: 4.330
Authors: David G Brauer; Ningying Wu; Matthew R Keller; Sarah A Humble; Ryan C Fields; Chet W Hammill; William G Hawkins; Graham A Colditz; Dominic E Sanford Journal: J Am Coll Surg Date: 2021-04-15 Impact factor: 6.532